Last updated: January 9, 2024
Sponsor: Ludwig-Maximilians - University of Munich
Overall Status: Active - Recruiting
Phase
N/A
Condition
Memory Loss
Mild Cognitive Impairment
Memory Problems
Treatment
ki:elements digital speech biomarker for cognition (ki:e SB-C)
Subjective cognitive decline questionnaire (SCD-Q)
Cognigram
Clinical Study ID
NCT06191952
22-0786
Ages > 65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- age 65 years or older
Exclusion
Exclusion Criteria:
- younger than 65 years
Study Design
Total Participants: 500
Treatment Group(s): 4
Primary Treatment: ki:elements digital speech biomarker for cognition (ki:e SB-C)
Phase:
Study Start date:
February 01, 2023
Estimated Completion Date:
February 01, 2024
Study Description
Connect with a study center
Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU Klinikums
München, Bayern 80336
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.